表紙
市場調查報告書
商品編碼
802339

感染創傷護理管理的全球市場:成長,趨勢,預測(2019∼2024年)

Infectious Wound Care Management Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

隨著人口增加,老齡化性疾病增加,創傷護理管理產品的需求也提高。還有糖尿病罹患率上升,事故,燒燙傷數量的增加對市場擴大也有所貢獻。

本報告提供全球感染創傷護理管理市場相關調查,市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介相關資訊彙整。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 市場趨勢

  • 市場概要
  • 推動市場的要素
    • 糖尿病罹患率的上升
    • 高齡化
    • 事故,燒燙傷數量的增加
  • 阻礙市場的要素
    • 創傷護理產品的使用不當和應用相關風險
    • 抗生素的副作用
  • 波特五力分析

第5章 市場區隔

  • 各產品類型
    • 治療
    • 設備
  • 各創傷類型
    • 糖尿病
    • 自體免疫疾病
    • 低氧症
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭環境

  • 企業簡介
    • Bristol-Myers Squibb Company
    • Cardinal Health Inc.
    • Sanofi
    • Smith & Nephew
    • Molnlycke Health Care AB
    • 3M
    • Kinetics Concept Company
    • Coloplast Group
    • Convatec Group PLC

第7章 市場機會與未來趨勢

目錄
Product Code: 61418

The growth of the market studied can be attributed to the increasing global geriatric population. As the population increases, age-related diseases are on the rise, thereby, bolstering the demand for wound care management products. The current market is also growing, due to the increasing prevalence of diabetes and rise in the number of the accidents and burns. These factors are fueling the growth of the market studied. Additionally, product innovations have increased in the recent years, in turn, boosting the growth of the infectious wound care management market.

Key Market Trends

Diabetes Mellitus Segment is Expected to Witness Fastest Growth Rate over the Forecast Period

  • Diabetic foot ulcer (DFU) is one of the chronic wounds that is very common in diabetic patients. It is prevalent in nearly 15% to 20% of the diabetes patients (as per Dong-il Chun et al., Journal of Clinical Medicine 2019). Its products range from normal saline to growth factors, ulcer dressings, and skin substitutes that have been shown to be highly effective in healing foot ulcers.
  • Furthermore, incidence of diabetes is expected to increase in future, as per the International Diabetes Federation 2019 report. In 2019, there were 463 million diabetic patients, worldwide, which is expected to increase to 578 million by 2030, as per the report statistics. Increasing incidence of diabetes is also expected to increase the incidence of DFU, which may increase the demand for the infectious wound care management market. This is expected to help the market growth.

North America Captured the Largest Market Share and is Expected to Retain its Dominance

  • The United States and Canada have a developed and well-structured healthcare system. These systems also encourage R&D activities. These policies encourage global players to enter the United States and Canada. As a result, these countries enjoy the presence of many global market players. Additionally, Mexico is a developing nation with the benefit of being neighbor to the United States. This allows many companies to penetrate in Mexico as well, which helps the growth in the region.
  • Moreover, incidences of chronic wounds, like diabetic foot ulcer, are expected to increase due to increasing incidence of diabetes. The International Diabetes Federation estimated that the incidence of diabetes may increase from 31 million in 2019 in the United States, to more than 34 million by 2030. This is expected to increase the demand for infectious wound care management products in the region, which may boost the market growth.

Competitive Landscape

Competition among the existing players is high and price pressure has been increasing among the vendors. Despite the higher number of market participants, majority of the market share is controlled by a handful of participants. The presence of a significant number of players in the market studied has an impact on the prices of products by firms, such as B Braun Melsungen AG, Cardinal Health Inc., Hartmann Group, Smith & Nephew PLC, and 3M Company, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Diabetes
    • 4.2.2 Rising Need for Wound Care in Aging Population
    • 4.2.3 Increasing Number of Accidents and Burn Cases
  • 4.3 Market Restraints
    • 4.3.1 Risks Associated with Improper Usage and Application of Wound Care Products
    • 4.3.2 Side Effects of Antibiotics
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Therapeutics
      • 5.1.1.1 Antibiotic Therapy
      • 5.1.1.2 Iodine Therapy
      • 5.1.1.3 Other Therapies
    • 5.1.2 Device
      • 5.1.2.1 Wound Dressing
      • 5.1.2.1.1 Film Dressing
      • 5.1.2.1.2 Silver Dressing
      • 5.1.2.1.3 Alginate Dressing
      • 5.1.2.1.4 Other Devices
      • 5.1.2.2 Compression Bandage
      • 5.1.2.3 Negative Pressure Wound Therapy
  • 5.2 By Type of Wound
    • 5.2.1 Diabetes Mellitus
    • 5.2.2 Hypoxia/Poor Tissue Perfusion
    • 5.2.3 Other Types of Wounds
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M Company
    • 6.1.2 B Braun Melsungen AG
    • 6.1.3 Cardinal Health Inc.
    • 6.1.4 Coloplast Group
    • 6.1.5 Convatec Group PLC
    • 6.1.6 Hartmann Group
    • 6.1.7 Molnlycke Health Care AB
    • 6.1.8 Smith & Nephew PLC
    • 6.1.9 Integra LifeSciences Holdings Corporation
    • 6.1.10 Hollister Incorporated

7 MARKET OPPORTUNITIES AND FUTURE TRENDS